Revised: 7 November 2019

Information for Healthcare Professionals

This section provides information useful to healthcare professionals.

Healthcare Professional Information

Safety Communications

Unapproved Medicines

Adverse Reaction Reporting

Subscribe

Medsafe Advice

Date Type Title
12/11/2019Monitoring CommunicationSuspected adverse reaction reports to lamotrigine after changing brands
12/11/2019Monitoring CommunicationUpdate 7 November 2019 - Breast Implants and anaplastic large cell lymphoma
7/11/2019Monitoring CommunicationEveret (levetiracetam) - supply and potential seizure control issues for patients
6/11/2019Alert CommunicationConsumer level recall of one lot of Avonex Pen 30mcg in 0.5mL, Lot 1422362
4/11/2019ConsultationConsultation on proposed changes to current warning and advisory statements for paracetamol
25/10/2019CommitteesMinutes of the 179th Medicines Adverse Reactions Committee Meeting
21/10/2019Monitoring CommunicationLosartan approved medicines supplied in New Zealand not affected by recalls overseas
21/10/2019Monitoring CommunicationReview of chemically synthesised active pharmaceutical ingredients for presence of nitrosamine impurity
21/10/2019Alert CommunicationMedicines containing ranitidine and a potential impurity, N-nitrosodimethylamine (NDMA)
11/10/2019NoticesMedsafe Office Closure Christmas/New Year 2019/2020
11/10/2019Alert CommunicationSurgical Mesh Implants - Adverse Event Reporting and Monitoring - Link to the latests October 2019 report
8/10/2019NoticesNotice of Medsafe Office Closure Christmas/New Year 2019/2020
1/10/2019ConsultationOutcome of consultation on the changes to the prescribing restrictions of riluzole
25/09/2019Dear Healthcare Professional LetterMMR II Vaccine - Additional supply of MMR II measles, mumps and rubella vaccine: differences in labelling and package inserts
23/09/2019Alert CommunicationMedicines containing ranitidine and a potential impurity, N-nitrosodimethylamine (NDMA)
19/09/2019Monitoring CommunicationUpdate - M² Logo Possible risk of lichen planus or lichenoid drug eruption with zoster (shingles) vaccine or influenza vaccine

If you have an enquiry that is not answered by the information on the web site please contact us at askmedsafe@health.govt.nz.

Show menus
0 1 2 4 5 6 7 9 [ /